(1)
Majidova, N.; Yaslıkaya, S.; Mıldanoglu, M. M.; Coskun, A.; Ercan Uzundal, D.; Sahin, T. K.; Akyildiz, A.; Akbas, S.; Camanlı, U.; Sahin, E. Efficacy of Second-Line Treatments After Atezolizumab and Bevacizumab in Advanced Hepatocellular Carcinoma and Related Prognostic Factors: A Multicenter Study by the Turkish Oncology Group (TOG). Turkish Journal of Gastroenterology 2025, 36, 293-301.